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ABSTRACT OF DISSERTATION 
 
 
 
 
 
ASSESSING NUMERACY IN ONCOLOGY: 
THE ROLE OF PATIENT PERCEPTION AND PREFERENCES 
 
Treatment decision making (TDM) in oncology is complex. Understanding 
treatment information is essential for shared TDM. Research suggests many patients have 
low numeracy. This mixed methods study explored numeracy and experience with 
numbers in a sample of individuals diagnosed with follicular lymphoma. Participants 
completed questionnaires (N = 32) and interviews (N = 20) assessing numeracy, 
decisional conflict and regret, and number preference. Results suggest that mean 
objective numeracy was relatively high, and most reported high confidence in numerical 
ability. Most participants preferred to receive numbers during the TDM process. There 
was no relationship between numeracy and decision outcomes. Future research should 
investigate the use of numeracy measures in practice and the impact of patient 
preferences and beliefs on shared TDM. 
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Chapter One: Introduction 
Background and Significance  
 
Assessing Numeracy in Oncology: The Role of Patient Perception and Preferences 
  
 Historically, medical TDM has primarily followed a paternalistic model (Charles, 
Gafni, & Whelan, 1999; Edwards & Elwyn, 2009). This model is becoming increasingly 
less common as more and more patients become active participants in the TDM process 
(Arora, 2003; Sheridan, Harris, & Woolf, 2004; Stiggelbout et al., 2006). This increase in 
patient participation in decision making has led to the development of a more 
collaborative, shared, or patient-centered approach to treatment communication (Apter et 
al., 2008; Edwards & Elwyn, 2009; Epstein, Alper, & Quill, 2004; Eggly et al., 2009; 
Sheridan, Harris, & Woolf, 2004). This process involves the participation of both patient 
and physician in sharing information, assessing patient preferences and needs, and using 
this information to collaboratively decide on a course for treatment (Sheridan, Harris, & 
Woolf, 2004). 
Patient involvement in this process has been found to have a number of positive 
psychological outcomes, including increased satisfaction, less anxiety and improved 
coping (Epstein & Street, 2007), and less regret about treatment decisions (Clark, Wray, 
& Ashton, 2001; Davison, So, & Goldenberg, 2007). Patients may also experience more 
trust in their physician and more confidence in their ability to participate in TDM when 
involved in the process. Additionally, patient participation in health care has also been 
shown to lead to improvements in health outcomes, such as medication compliance 
(Adams, Appleton, Wilson, & Ruffin, 2005).  
Despite these positive outcomes, research in this field has uncovered significant 
challenges regarding patient involvement in TDM. Specifically, there is strong evidence 
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to suggest that the majority of patients have limited understanding of the treatment 
information they are presented (Gigerenzer, Gaissmaier, Kurz-Mileke, Schwartz, & 
Woloshin, 2008; Moxey, O’Connell, McGettigan, & Henry, 2003; Nelson, Reyna, 
Fagerlin, Lipkus, & Peters, 2008). This lack of understanding limits the ability for 
patients to participate in a shared or collaborative TDM process, make an autonomous 
decision about their care, and to truly provide informed consent for treatment (O’Connor, 
Stacey, & Jacobsen, 2011; Sheridan, Harris, & Woolf, 2004; Sullivan, 2003). Effective 
health communication is necessary to ensure that patients make an informed choice based 
on adequate understanding. Ineffective communication can have serious consequences 
for patients, including reduced treatment adherence, decreased use of preventative 
services, (Vahabi, 2007) and inadequate understanding of the seriousness of their disease 
and the risk and benefits of treatment (Sheridan, Harris, & Woolf, 2004).  
This is of particular concern in the oncology setting. TDM in this setting is often 
more complex due to the nature and gravity of the illness. Cancer TDM commonly 
involves weighing multiple treatment options with ranging benefits and risks. Patients 
making these decisions have the added burden of knowing that the choice will likely 
result in trade offs between survival and quality of life. Research has also highlighted the 
unique emotional environment in which cancer treatment decisions are made. There is 
evidence to suggest that a diagnosis of cancer causes significant emotional distress, 
symptoms of posttraumatic stress, anxiety, and depression, and a reduction in 
psychological well-being (Cordova et al., 1995; Costanzo, Ryff, & Singer, 2009; 
McBride, Clipp, Peterson, Lipkus, & Demark-Wahnefried, 2000). The emotional distress 
that patients experience following a cancer diagnosis may significantly increase the 
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difficulty with which they are able to weigh different treatment options (Diefenbach et 
al., 2008; Fischoff, 1999). Cancer patients are required to organize and consider complex 
treatment information in light of their own preferences for treatment at a time when their 
capacity for decision making is likely impaired because of these strong emotions 
(Consedine & Moskowitz, 2009; Rini et al., 2009). In addition, there are some cancers, 
such as follicular lymphoma, in which research has not produced definitive evidence that 
any of the available treatment options increase survival, adding to the complexity and 
uncertainty regarding which treatment to choose. 
Effective treatment communication is complex. One necessary, but often 
challenging component is to provide patients with numerical treatment information, such 
as probabilities of side effects or treatment response, in order for them to make a 
treatment choice based on accurate information (Apter et al., 2009; Fischoff, 1999; 
Reyna, Nelson, Han, & Dieckmann, 2009). However, this process is complicated by the 
lack of numeracy in the general population (Nelson et al., 2008; Reyna, Nelson, Han, & 
Dieckmann, 2009) and the emotional nature of a cancer diagnosis as noted above. It is 
therefore essential to identify cost-effective methods to reduce the burden experienced by 
cancer patients who wish to be actively involved in the treatment process. Examining 
numeracy and how it impacts understanding of treatment information and subsequent 
treatment decisions is one potential means of simplifying this process for patients. Using 
a mixed methods approach, this study proposes to examine the utility of subjective and 
objective numeracy measures and the relationship between numeracy and TDM in a 
sample of individuals previously diagnosed with follicular lymphoma. This study will 
incorporate a qualitative approach to describe patient’s experiences with numeracy and 
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preferences for communication about quantitative treatment information during oncology 
treatment consultation.  
Numeracy and TDM 
Numeracy and Informed Consent 
Recent research on numeracy, an individual’s ability to comprehend and utilize 
numerical information, demonstrates that a large proportion of individuals struggle with 
basic numerical operations (Fagerlin et al., 2007; Galesic & Garcia Retamero, 2010; 
Lipkus, 2007; Reyna & Brainerd, 2007; Reyna, Nelson, Han, & Dieckmann, 2009; 
Peters, Hibbard, Slovic, & Dieckmann, 2007). This difficulty with comprehension of 
quantitative information has also been found in the TDM setting. A study by Weinfurt et 
al. (2005) demonstrated that a substantial proportion of patients making decisions about 
clinical trial participation misunderstood the statement “For every 100 patients like me, 
the treatment will work for 40 patients.” Twenty-eight percent of participants understood 
this statement to mean that their doctor had 40% confidence that the treatment would 
control their cancer or that the treatment would reduce their disease by 40%. This lack of 
understanding of basic percentages and probabilities may significantly impact the ability 
of patients to weigh the benefits and risks of various treatments and choose one that fits 
with their personal preferences. 
Patients are not only hindered by their level of understanding of numerical 
concepts and operations, but may also change their treatment decisions based on the 
format in which treatment information is presented (Garcia-Retamero & Galesic, 2010; 
Moxey et al., 2003; Nelson et al., 2008; Peters, Hart, & Fraenkel, 2011). There have been 
a number of studies using cancer treatment information that have demonstrated a 
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significant effect of the frame used to present information on the type of treatment 
chosen. Framing is defined as the presentation of logically equivalent information in 
different ways that may bias how an individual interprets the information (Wilson, 
Purdon, & Wallston, 1988). For example, presenting a risk of mortality as a 20% risk of 
death (negative frame) may be interpreted differently than presenting it as an 80% chance 
of survival (positive frame) despite the fact that these are logically equivalent ways of 
describing the same risk. Studies examining positive and negative framing have 
demonstrated that the use of frames bias individuals toward either a risk-approach or risk-
avoidance treatment choice (McNeil, Pauker, Sox, & Tversky, 1982; McNeil, Pauker, & 
Tversky, 1988; O’Connor et al., 1985; O’Connor, 1989). 
 Patients that have low health literacy and numeracy are often more susceptible to 
framing effects and overestimate risk more than those with higher literacy and numeracy 
(Reyna, Nelson, Han, & Dieckmann, 2009). Health literacy includes having an accurate 
understanding of general health information, as well as of disease, the health care 
process, and health terms (Epstein & Street, 2007). Health numeracy is somewhat 
dependent upon health literacy, and involves the ability to understand and manipulate 
numbers used in a health context and then act on that health information to promote good 
health (Lipkus & Peters, 2009, Nelson et al., 2007). Studies have shown that those with 
lower health numeracy and literacy also face negative health consequences. A study of 
patients using warfarin for therapy found that those with lower health numeracy and 
literacy had poor anticoagulation control and were unable to correctly titrate their 
medication to remain in a therapeutic range (Estrada, Martin-Hryniewicz, Peek, Collins, 
& Byrd, 2004). Another study examining diabetes-related numeracy in diabetic patients 
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found that lower numeracy was associated with lower perceived self-efficacy and fewer 
self-management behaviors (Cavanaugh, Huizinga, Wallston, Gabretsadik, Shintani, 
Davis, et al. 2008) This research raises significant concerns about presenting treatment 
information to patients in numerical terms.  
Based on the evidence that many individuals have difficulty understanding 
numerical information, other studies have examined the effectiveness of communicating 
treatment information in a qualitative form (Cheung et al., 2010; Wallsten, Budescu, 
Zwick, & Kemp, 1993; Windschitl & Wells, 1996). This involves using qualitative 
descriptors such as “unlikely,” “rare” or “sometimes” to present treatment information. 
Research on the use of qualitative descriptors in cancer TDM has not demonstrated that 
this type of communication is preferential to providing quantitative treatment information 
(Gurmankin et al., 2004; Knapp, Gardner, Carrigan, Raynor, & Woolf, 2009; Knapp, 
Gardner, Raynor, Woolf, & McMillan, 2010; Young & Oppenheimer, 2009). These 
studies have found that patients tend to overestimate risk and misinterpret treatment 
information regardless of whether the information is provided in a qualitative or 
quantitative form. 
Accurate understanding of treatment information is essential in order for patients 
to be able to participate in a collaborative TDM process and provide informed consent for 
treatment. Problems with basic understanding of numerical information and the influence 
of communication format on understanding significantly hinder the ability of patients to 
make informed treatment decisions (Reyna, Nelson, Han, & Dieckmann, 2009). In the 
oncology setting, patients make challenging treatment decisions that often have 
significant consequences for survival and quality of life. Therefore, it is essential that 
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patients accurately understand the risk and benefits of treatment. To ensure that patients 
are making an optimal treatment decision based on accurate understanding, it is necessary 
to continue investigating methods to improve this process for patients. Learning more 
about patient’s familiarity with and facility for numbers may aid in the design of 
treatment communication that patients can comprehend and apply in their decision 
making processes.  
Assessment of Numeracy 
Numeracy has been demonstrated to play a significant role in patient’s medical 
decisions, and low numeracy has been associated with less understanding and use of 
health information (Fagerlin et al., 2007; Peters, Hibbard, Slovic, & Dieckmann, 2007). 
One possible means of improving the TDM process would be to tailor numerical 
information to a patient’s desire for and ability to comprehend it. However, to do this, it 
is necessary to systematically assess each patient’s level of numeracy. This would 
provide the patient’s health care team with essential information that can aid in the 
development of more effective treatment communication efforts. Once information is 
received about a patient’s level of numeracy, interventions can then be implemented to 
tailor the information they receive to match their skills and preferences. Ideally, this 
would maximize the likelihood that the patient will leave the treatment consultation with 
an accurate understanding of their treatment options.  
Most research has focused on objective measures of numeracy that test patients’ 
ability to calculate percentages, frequencies, and probabilities. Objective numeracy 
assessments provide information regarding patients’ skills in basic numerical operations. 
Since numeracy is not accurately determined either by observable traits or self-report 
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(Nelson, Reyna, Fagerlin, Lipkus, & Peters, 2008), brief objective numeracy measures 
can help physicians identify those who may have difficulty understanding quantitative 
information. Schwartz, Woloshin, Black, and Welch (1997) developed a brief measure of 
numeracy that has been used to assess the relationship between numeracy and ability to 
use risk reduction information. Their questionnaire assesses numeracy using three 
questions measuring familiarity with probability, percentages, and proportions. The 
authors found that those with higher numeracy were more accurate at applying 
mammography risk reduction information. These results highlight the difficulty that low 
numeracy patients are likely to have with quantitative treatment information.  
Lipkus, Samsa, and Rimer (2001) expanded Schwartz and colleague’s (1997) 
three-item scale. This newer instrument added eight items that were framed in the context 
of health risks. This instrument is now widely used to assess objective numeracy in a 
health setting (Nelson et al., 2008). Despite the benefits of assessing objective numeracy, 
there are some inherent complications with using these measures in practice. The time 
necessary to complete the task and the difficulty patients may have in completing it may 
result in frustration, missing data, or refusal to complete the measures (Fagerlin, Ubel, 
Smith, & Zikmund-Fisher, 2007; Nelson, Reyna, Fagerlin, Lipkus, & Peters, 2008). 
An alternative method to objective measures of numeracy is the measurement of 
subjective numeracy, or a patient’s self-rated mathematical aptitude. Measures of 
subjective numeracy have recently been developed to address concerns regarding the 
aversion some patients have to completing objective numeracy measures as well as the 
difficulties completing these measures by phone or mail. The Subjective Numeracy Scale 
(Fagerlin et al., 2007) is a leading example of a recently-validated measure of subjective 
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numeracy. It contains two subscales; one measuring patient’s self-reported mathematical 
aptitude, and one measuring preference for receiving mathematical versus descriptive 
information. The authors reported a correlation of .68 between the subjective numeracy 
measure and the Lipkus, Samsa, and Rimer (2001) 11-item numeracy scale. This measure 
of subjective numeracy provides valuable information regarding the patient’s perceived 
ability to work with numbers as well as their preference for working with numbers. 
However, this scale was validated on general medical patients and the general public. It is 
yet unknown if subjective and objective numeracy correlate as highly in a group of 
cancer patients that have experience with making treatment decisions. Before utilizing 
subjective numeracy as a proxy for objective numeracy in a cancer population, it is 
necessary to examine the construct validity of subjective numeracy in an oncology setting 
due to the unique nature of a cancer diagnosis and subsequent TDM process.  
Numeracy and Decision Outcomes 
An understudied aspect of numeracy is the impact that one’s level of numeracy 
has on decision outcomes. While there is evidence to indicate that one’s numeracy 
impacts treatment choice (Garcia-Retamero & Galesic, 2010; Nelson et al., 2008), there 
have been no studies examining the impact of numeracy on relevant decision-related 
outcomes, including how patients feel about their treatment choice. A low level of 
numeracy may increase the conflict that patients experience about their treatment 
decision due to confusion or uncertainty about the best treatment choice for them. Using 
the Ottawa Decision Support Framework, decisional conflict and regret were chosen as 
the decision-related outcomes to examine. This conceptual framework presents decisional 
conflict, or uncertainty, about a decision as a central decision need that must be addressed 
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in order to make an informed, quality decision (O’Connor, Stacey, & Jacobsen, 2011). 
Decision regret was also included as a decision-related outcome based on prior evidence 
suggesting that patients who experience greater conflict surrounding their treatment 
decision later experience more regret about their decision (Brehaut et al., 2003). This may 
have important implications for future treatment decisions, particularly in populations of 
patients that are required to make multiple treatment decisions.  
Patient Preferences 
Preference for Communication Format 
Patient preferences for communication format are another important aspect of the 
TDM process. Findings from studies examining the use of tailored health information 
have found that this can have significant positive outcomes: tailored health messages are 
more likely to be read and remembered, are rated as more attention catching, and are 
perceived as being more personally relevant (Hawkins, Kreuter, Resnicow, Fishbein, & 
Dijkstra, 2008; Kreuter & Wray, 2003). Petty and Cacioppo’s Elaboration Likelihood 
Model posits that people are more likely to be active and thoughtful when processing 
information when they are motivated and able to do so. The model further suggests that 
one of the essential components of motivation is perceived personal relevance of the 
message (Petty & Cacioppo, 1981).  
This model provides a structure for understanding how personal preference for 
treatment communication format may influence subsequent retention and understanding. 
Patients who receive treatment information that is not in a format they prefer, such as 
receiving numerical information when they prefer verbal information, may not be 
motivated to attend actively to and process the information given to them. This could 
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potentially increase the difficulty they would have comprehending and applying the 
treatment information they receive to make a treatment decision.  
Patient preferences for treatment communication format have rarely been studied 
in the oncology setting. A recent review (Poe, 2010) identified only four studies that have 
assessed patient preferences for communication format in a cancer setting. The results 
from these studies demonstrated that most patients had a preferred mode of receiving 
information, but that this preference varied widely, emphasizing the importance of 
assessing preferences in all patients (Knapp et al., 2010; Lobb et al., 1999; Mazur, 
Hickam, & Mazur, 1999; Studts et al., 2005). Two of the studies (Lobb et al., 1999; 
Studts et al., 2005) provided qualitative data on why patients had preferences for 
particular communication formats. For example, some patients reported that different 
forms of communication seem confusing or negative; while others may perceive the same 
form of communication more positively (Lobb et al., 1999; Studts et al., 2005). It is likely 
that patients have preferences for receiving treatment information that is based on their 
level of understanding or comfort with a particular format. Patient’s preferences for 
qualitative information may reflect a discomfort with numbers, or a preference for 
information in a positive frame may demonstrate a misunderstanding of equivalent 
numerical estimates. It may be important to assess both level of numeracy and patient 
preferences in all patients before they receive information about their treatment options. 
TDM in Follicular Lymphoma 
Reducing the burden of the TDM process is particularly important in cancers 
where patients are required to make multiple treatment decisions, such as follicular 
lymphoma. Follicular lymphoma is a non-Hodgkin lymphoma, and it is considered an 
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indolent, or slow-growing, cancer that is located in the lymph nodes (Advani, Rosenberg, 
& Horning, 2004; Conconi et al., 2010; van Besien & Shouten, 2007). Patients with 
follicular lymphoma survive a median of nine to ten years, and generally die as the result 
of treatment-resistant disease, the transformation to a more aggressive pathology, or from 
complications of therapy (Conconi et al., 2010; Rohatiner & Lister, 2005). Advanced 
stage disseminated indolent lymphomas are generally considered incurable and are 
characterized by a repeated, initial response to treatment that is transient, and subsequent 
repeated relapse (Advani, Rosenberg, & Horning, 2004; Rohatiner & Lister, 2005; Salles 
et al., 2011). This recurrent relapse requires follicular lymphoma patients to make 
multiple treatment decisions over their disease trajectory.  
Although numerous treatment approaches have been used in this patient 
population, none have resulted in long-term survival without cancer in a large percentage 
of patients (Ardeshna et al., 2003; Conconi et al., 2010; Horning, 2000; Linch, 2001). 
Because patients will experience multiple relapses with little hope for a definitive cure of 
their disease, treatment often focuses on controlling the disease rather than curing it 
(Wake et al., 2002). Additionally, a recent study with follicular lymphoma patients (Poe, 
Hayslip, & Studts, in press) revealed that a majority of patients reported significant 
anxiety and cancer-specific distress. These unique characteristics make the TDM process 
for patients with follicular lymphoma particularly complex. However, there has been 
little research investigating the decision making process among individuals diagnosed 
with follicular lymphoma.  
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Aims and Hypotheses 
The increase in patient participation in decision making has led to a shift from a 
paternalistic, physician-driven decision making process to a more collaborative, patient-
centered process (Eggly et al., 2009; Epstein, Alper, & Quill, 2004; Sheridan, Harris, & 
Woolf, 2004). This shift has had positive outcomes for patients (Adams, Appleton, 
Wilson, & Ruffin, 2005; Clark, Wray, & Ashton, 2001; Davison, So, & Goldenberg, 
2007; Epstein & Street, 2007). However, research highlighting deficits in patient 
understanding of treatment information raises interest in improving the process of 
communicating treatment information. Clearly communicating treatment information to 
patients is an essential factor in the development of collaborative patient-physician 
relationships and the provision of quality health care (Arraras et al., 2007; Sheridan, 
Harris, & Woolf, 2004; Vahabi, 2007). The assessment of patient numeracy and 
preferences for communication format is one potential method of improving this process. 
This information can aid in the development of time and cost-effective interventions that 
address the barriers to understanding treatment information and facilitate informed TDM. 
In addition, although it is known that lack of numeracy and communication format can 
influence treatment decisions, it is yet unknown what impact this has on important 
decision outcomes that may affect future treatment decisions.  
To address these gaps in the literature, this study employed a mixed methods 
approach (Creswell, 2003; Creswell & Plano Clark, 2007; O’Cathain, Murphy, & 
Nicholl, 2010) to investigate these issues in a sample of individuals previously diagnosed 
with follicular lymphoma. Mixed methods research involves the collection, analysis, and 
integration of both quantitative and qualitative data to answer research questions 
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(Creswell & Plano Clark, 2007; O’Cathain, Murphy, & Nicholl, 2010). The use of a 
mixed method approach has several advantages. Mixed methods research integrates both 
quantitative and qualitative data on a topic, providing a way for researchers to study 
similar data from different perspectives (Creswell, 2004; Tashakkori & Creswell, 2007). 
The use of quantitative data alone on understudied topics may result in the design of 
measures that do not fully incorporate all important aspects of a phenomenon (Creswell, 
2003). The inclusion of qualitative data adds the perspective of the population being 
studied, which may further refine current quantitative measures or lead to the 
development of future quantitative measures (Cagle & Wells, 2008). The use of a 
qualitative approach also provides information on themes that may be present, and thus 
can further inform later quantitative research (Creswell & Plano Clark, 2007). One 
potential disadvantage of the mixed methods approach is difficulty with successful 
integration of the data from both methods (Bryman, 2007; Creswell, 2003; O’Cathain, 
Murphy, & Nicholl, 2010). The current study employed a concurrent mixed methods 
approach (Creswell & Zhang, 2009). In this approach, quantitative and qualitative data 
are collected at the same time point. The data are then analyzed separately, and the results 
are merged in the interpretation. Trends in the quantitative and qualitative data are 
examined to determine how the results from the two methods corroborate, support, or 
contradict each other (Creswell & Zhang, 2009).  
In this study, the qualitative interview data was used to enhance the quantitative 
data on objective and subjective numeracy. The inclusion of the qualitative data 
supported the quantitative data by describing the patient’s experience and comfort with 
numbers in the TDM process. In addition, the qualitative data extended this further by 
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describing patient’s experiences that are not captured by the quantitative measures. The 
research questions in this study will be most effectively answered through the integration 
of these two methods of data collection, making a mixed methods approach the most 
appropriate research methodology. 
The overall goal of this project was to explore numeracy and patient experience 
with numbers in a sample of follicular lymphoma patients. The first aim of this study was 
to examine the psychometric properties of the Subjective Numeracy Scale and to explore 
the construct validity of subjective numeracy in an oncology setting. It was hypothesized 
that subjective numeracy will be significantly and positively correlated with objective 
numeracy. The second aim of this study was to examine the relationship between 
subjective and objective numeracy and measures of TDM. It was hypothesized that 1) 
subjective and objective numeracy would be significantly and negatively correlated with 
decision regret and 2) subjective and objective numeracy would be significantly and 
negatively correlated with decisional conflict. Finally, the third aim of this study was to 
utilize qualitative interview data to provide additional information about numeracy by 
exploring and describing: 1) patient reports of the use of numbers in the clinical 
consultation and perceived ability to work with numbers, and 2) patient perception of and 
preference for the use of numbers in TDM. Data for this study was taken from a 
previously conducted study of the TDM processes in individuals diagnosed with 
follicular lymphoma.  
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Chapter Two: Method 
Accrual Procedure 
Eligible study participants were identified from clinic records at the University of 
Kentucky’s Markey Cancer Center. Prior to contacting eligible candidates, permission to 
contact specific patients was sought from their treating oncologist. After receiving 
oncologist permission, individuals were approached at the clinic or contacted by letter 
and invited to participate in a study that would involve completing a questionnaire 
packet. Participants were compensated $25 for completing and returning the packet. 
Participants were also asked to participate in an in-person or telephone semi-structured 
interview. A trained interviewer completed these interviews using a semi-structured 
interview guide. Individuals who completed the interview received an additional $50. 
Participants 
 Adults with a diagnosis of follicular lymphoma were recruited from the 
University of Kentucky’s Markey Cancer Center in Lexington, Kentucky. All study 
procedures were reviewed and approved by the Institutional Review Board at the 
University of Kentucky. Participants were invited regardless of current treatment status. 
Participants were eligible if they were: (a) age 18 or older; (b) had a cancer diagnosis of 
follicular lymphoma with no other cancer history (other than non-melanotic skin cancer); 
(c) diagnosed in the last 10 years; (d) and able to read and write English.  
A total of 69 eligible participants were identified and sent a letter of invitation to 
participate in the study. Of the 69 eligible participants, 4% (n= 3) were deceased, 4% (n = 
3) declined participation, and 36% (n = 25) did not respond to the invitation letter. A total 
of 59% (n = 39) indicated interest in study participation. Of these, 36 individuals 
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provided informed consent. Ultimately, 32 completed questionnaire packets were 
received for a final completion rate of 48% (32/66). Of those that completed the 
questionnaires, 20 individuals also completed the interview. The average interview time 
was 27.7 minutes (SD = 14.7; range = 11.2-66.3). 
Measurement: Quantitative 
 Participants (N = 32) completed a questionnaire that included five sets of 
instruments: (1) a background/medical information questionnaire, and measures assessing 
(2) role preferences in TDM, (3) numeracy, (4) treatment decision outcomes, (5) 
psychological distress. The measures relevant to this study will be described below.  
Subjective Numeracy 
 Participants were administered the Subjective Numeracy Scale (SNS; Fagerlin et 
al., 2007). The scale was developed to address concerns regarding the measurement of 
objective numeracy, such as distance administration and negative reactions from 
individuals completing objective numeracy scales. The scale includes eight items and 
comprises two subscales. Participants were asked four questions regarding their 
perceived ability to calculate percentages and fractions and four questions regarding 
preferences for receiving numerical or verbal information. Participants responded by 
circling a number from 1 (not at all) to 6 (extremely). One subscale measures patient’s 
self-reported mathematical aptitude, and one measures preference for receiving 
mathematical versus descriptive information. Possible scores range from 8 to 48 on the 
full scale and 4 to 24 on the subscales. Higher scores indicate a higher aptitude and 
preference for numerical information. The final scale demonstrated good reliability in the 
validation sample (.82) and the authors reported a correlation of .68 with Lipkus, Samsa, 
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and Rimer’s numeracy scale (2001). The internal consistency was not reported for either 
subscale in the validation study. The SNS has not been previously used in an oncology 
setting. 
 In this sample, reliability analyses revealed a Cronbach’s alpha of .90 for the full 
scale of the SNS, demonstrating good reliability. The mean of the full scale was 34.6 (SD 
= 9.9). The mean score of the aptitude subscale was 16.9 (SD = 5.8), and the mean of the 
preference subscale was 17.8 (SD = 4.8). 
Objective Numeracy 
 To measure objective numeracy, participants were administered the 11-item 
Numeracy Scale (Lipkus, Samsa, & Rimer, 2001). This is a widely used scale comprised 
of questions measuring familiarity with probability, ability to covert a percentage to a 
proportion, and the ability to convert a proportion to a percentage. The score is calculated 
by counting the number of correct responses. It has been found to have adequate internal 
consistency (.70 to .75). In validation samples, between 29% to 34% of participants 
correctly answered all questions (Lipkus, Samsa, & Rimer, 2001). The 11-item 
Numeracy scale demonstrated good internal consistency in the current study sample 
(.84). The mean score on the 11-item Numeracy Scale in the study sample was 8.06 (SD 
= 2.5).  
Decision Regret 
To measure regret pertaining to the participants’ most recent treatment decision, 
the Decision Regret Scale (DRS) was used (Brehaut, et al., 2003). This five-item measure 
was developed to assess regret as a function of a health care decision. Participants were 
asked to reflect on their most recent treatment decision and indicate the extent to which 
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they agreed with the items by circling a number from 1 (strongly agree) to 5 (strongly 
disagree). Two of the items were negatively phrased to avoid yea-saying bias. Scoring 
consisted of reversing the scores of the two negatively phrased items and then taking the 
mean of all five items. The means are then converted to a score ranging from 0 to 100 by 
subtracting 1 and multiplying by 25. Higher scores indicate greater regret. In the 
validation samples, reported regret was fairly low, with the mean item scores falling well 
below the middle of the scale across validation groups. Convergent validity analyses 
demonstrated medium to large correlations with measures of decision satisfaction, 
decision conflict, and quality of life. This measure was validated on a sample of newly 
diagnosed breast cancer and prostate cancer patients, and reliability estimates in the 
validation sample ranged from .81 to .86, depending on the sample. The reliability of the 
DRS in this sample was consistent with the validation sample (.87). The mean score on 
the total DRS was 14.2 (SD = 15.5).  
Decisional Conflict  
To assess conflict patients experienced when making a treatment decision, 
participants were administered the Decisional Conflict Scale (O’Connor, 1995). The 
Decisional Conflict Scale (DCS) includes 16 items and was developed to elicit: 1) health-
care consumers’ uncertainty in making a health-related decision; 2) factors contributing 
to the uncertainty; and 3) health-care consumers’ perceived effective decision making. 
The uncertainty subscale contains 3 items, the factors contributing to uncertainty subscale 
contains 9 items, and the effective decision making subscale contains 4 items. 
Respondents are asked to consider treatment decisions they have just made or are about 
to make and to respond using a five-point Likert scale. Responses are scored from 1 
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(strongly agree) to 5 (strongly disagree). Negative statements are reversed scored, with 
high scores indicating higher decision conflict. Possible scores on the full scale DCS 
range from 16 to 80. Possible scores on the subscales of the DCS are as follows: 
Uncertainty subscale, 3 to 15; Factors contributing to uncertainty subscale, 9 to 45; 
Effective decision making subscale, 4 to 20. The DCS has previously been used in 
oncology settings to assess decisional conflict in cancer patients, and has been reported to 
have a reliability estimate between .75 and .97 (Dolan & Frisina, 2002; Koedoot et al., 
2001; Mancini, Santin, Chabal, & Julian-Reynier, 2006). Construct validity was tested by 
comparing DCS scores with decisions to accept, reject, or delay a decision to participate 
in cancer screening, as well as knowledge about the risks of breast cancer. Those who 
had delayed or were unsure about screening had higher scores on the DCS. In addition, 
those with higher scores on the DCS also had less knowledge of breast cancer risks, 
adequately demonstrating that the DCS measures the construct of decisional conflict 
(O’Connor, 1995). In this sample, the full scale reliability of the DCS was good (.87). 
The mean score on the full scale of the DCS was 31.6 (SD = 8.1). 
Measurement: Qualitative 
 The analysis of the interview data involved both quantitative content analysis 
(Hsieh & Shannon, 2005; Rourke & Anderson, 2004) and qualitative description 
(Sandelowski, 2000). The interview was comprised of questions on the use of numbers 
during treatment consultations. The responses to the following interview prompts will be 
reported in this study: “Sometimes doctors use numbers to describe benefits and risks of 
different treatment options. Do you remember if your oncologist or your doctor used 
numbers in your most recent treatment consultation that involved making a treatment 
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decision?”; “What do you think about using numbers to talk about treatment options?”; 
“Would you prefer your doctor to use numbers to talk about treatment options?”; “Do 
you think you are able to understand numbers used to talk about treatment options?.” The 
interviews were digitally recorded and transcribed. 
Data Analysis 
Quantitative Data Analysis  
Criterion & Power Calculation 
The criterion to determine statistical significance for all statistical analyses was p 
<.05 (two-tailed). Correlations were assessed using Cohen’s criteria (Cohen, 1992). A 
small effect for a correlation is indicated by .10, a medium effect by .30, and a large 
effect by .50. A post hoc power analysis based on a sample of 32 participants estimated a 
power of .14 to detect a small effect, .54 to detect a medium effect, and .94 to detect a 
large effect. Alternatively stated, the study has power of .80 to detect statistically 
significant correlations of .45 or greater. 
Hypothesis tests 
Hypothesis 1: Subjective numeracy will be significantly and positively correlated 
with objective numeracy. To test this hypothesis, a Pearson product moment correlation 
was conducted to determine the degree of relationship between scores on the Subjective 
Numeracy Scale (and its two subscales) and scores on the 11-item Numeracy Scale. A 
large effect is hypothesized, based on the previous findings by Fagerlin et al. (2007).  
Hypothesis 2a: Subjective and objective numeracy will be significantly and 
negatively correlated with decision regret. A Pearson correlation was conducted to 
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determine the degree of the relationship between scores on the Subjective Numeracy 
Scale, 11-item Numeracy Scale, and scores on the Decision Regret Scale. 
Hypothesis 2b: Subjective and objective numeracy will be significantly and 
negatively correlated with decisional conflict. A Pearson correlation was conducted to 
determine the degree of the relationship between scores on the Subjective Numeracy 
Scale, 11-item Numeracy Scale, and scores on the Decisional Conflict Scale.  
The quantitative questionnaire data was analyzed using the Statistical Package for 
the Social Sciences (SPSS) version 18.0 and compared to the qualitative data. 
Qualitative Data Analysis 
  Quantitative Content Analysis 
First, interview transcripts were reviewed using quantitative content analysis 
(Hsieh & Shannon, 2005; Rourke & Anderson, 2004). Questions were developed based 
on the original interview guide and then categorized by the response. Dichotomous 
questions asked during the interview were captured for quantitative content analysis. A 
second rater coded this data to ensure adequate inter-rater reliability, and kappa 
coefficients for each question were calculated. Kappa values were high, indicating 
substantial agree between raters. These questions included: “Did your oncologist used 
numbers during your treatment consultation?” (Kappa = .89, p < .001); “Would you 
prefer your doctor to use numbers to talk about treatment options?” (Kappa = .82, p < 
.001); “Do you think you are able to understand numbers used to talk about treatment 
options?” (Kappa = 1.0, p < .001). Responses indicating “yes” or “no” were tallied and 
reported along with the qualitative data. The in-depth content explaining why these 
responses were chosen was described using a qualitative descriptive approach, described 
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in the next section. These responses were also compared to responses on the quantitative 
questionnaires, and any consistencies or discrepancies between the two are discussed.  
Qualitative Descriptive Analysis 
After tallying responses to the dichotomous interview questions, the interview 
transcripts were analyzed using a qualitative descriptive approach (Sandelowski, 2000). 
This method is particularly useful for data that provides a straightforward answer to an 
investigator’s question. This approach utilizes a low-inference method of reporting 
qualitative data. Qualitative data using this method provides a summary of the facts of the 
data in everyday language. The focus is on providing an accurate description of the 
experience of the participants, rather than interpreting the data according to a particular 
theory, framework, or system (Sandelowski, 2000). The codes used to interpret the data 
are derived from the data itself, rather than the application of a series of pre-determined 
codes developed by the researcher (Sandelowski, 2000). Thus, this data was not 
interpreted in light of a particular theory or framework.  
The step-by-step analysis was guided by a general analysis approach described by 
Creswell (2007). The analysis began with multiple readings of the relevant portions of the 
interview transcriptions by one rater. While reading through the trancriptions, notes were 
made on the most commonly occurring themes. From these notes, a preliminary 
codebook was developed based on the codes extracted from the data. The rater then 
repeated this process by re-reading the transcripts, making notes, and identifying codes a 
second time. This allowed the rater to compare concordant and discordant codes from the 
first and second analysis. The second iteration of this process was then used to refine and 
clarify the first codebook into the development of a final codebook (2.0).  
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After the development of the final codebook, the data was again re-read and 
coded according to the themes. After final coding, themes were collapsed into broader 
categories. Following the development of the codebook, the Atlas.ti version 5.2 
qualitative data software program was used to organize segments of texts by the 
identified themes. 
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Chapter Three: Results 
Sample Description 
 A total of 32 individuals provided informed consent and completed the study 
questionnaire. Twenty individuals completed the interview portion of the study in 
addition to the questionnaire. Participants were predominately female (59%), Caucasian 
(94%), and married (81%) and were an average age of 57 (SD = 10.2; range = 36-78). 
Eighty-four percent of the sample identified themselves as having a Christian religious 
affiliation, and more than half (58%) of the sample reported attending religious services 
once or more per week. Two-thirds of the sample reported an annual household income 
of less than $70,000. Approximately half of the sample reported working at least part-
time (48%), and twenty-percent of participants reported being permanently unemployed 
due to sickness. Participants were an average of four years since diagnosis (SD = 3.1; 
range = 1 to 10) and an average of 12 months since their most recent treatment decision 
(SD = 17.3; range = 1 to 72). See Table 1 for a complete demographic description of the 
sample. 
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Table 1 
Demographic and Clinical Variables of the Sample 
________________________________________________________________________ 
Variable     M SD  % of Patients  Frequency 
______________________________________________________________________________ 
Age 57  10.5  
Gender 
 Male     40.6%  19 
 Female     59.4%  13 
Number of Children 2.2  1.2 
 Had Children    93.7%  30  
Marital Status 
 Married    81.2%  26   
 Unmarried    18.8%  6 
Race 
 White, Non-Hispanic    93.7%  30 
 Black, Non-Hispanic    3.3%  1 
 Not Reported    3.3%  1 
Religious Affiliation 
 Christian    84.3%  27 
 No religious affiliation    6.2%  2 
 Other    6.2%  2 
 Not Reported    3.3%  1 
Annual Income 
 Less than $25,000    18.8%  6 
 $25,000 to $39,999    18.8%  6 
 $40,000 to $54,999    6.3%  2 
 $55,000 to $69,999    21.9%  7 
 $70,000 to $84,999    9.4%  3 
 $85,000 to $100,999    12.5%  4 
 More than $100,000    12.5%  4 
Current employment status 
 Full time    37.5%  12 
 Part time    9.4%  3 
 Housewife or homemaker    9.4%  3 
 Temporarily unemployed    3.2%  1 
 Retired    15.6%  5 
 Permanently unemployed due to sickness    18.8%  6 
 Permanently unemployed, with independent means  3.2%  1 
 Not Reported    3.2%  1 
Insurance status 
 Medicare    12.5%  4 
 Medicaid    6.3%  2 
 Private    25%  8 
 HMO/PPO    56.2%  18 
______________________________________________________________________________ 
Note: Percentages may not add to 100 due to rounding.  
 
27 
 
Quantitative Data Analysis  
Properties of the Subjective Numeracy Scale 
 To address the first study aim, an examination of the psychometric properties of 
the SNS, analyses were conducted to describe scale properties including internal 
consistency reliability and construct validity. Reliability analysis revealed a Cronbach’s 
alpha of .90 for the full scale of the SNS, demonstrating good reliability. The subscales 
also demonstrated adequate reliability (aptitude subscale = .92; preference subscale = 
.78).  
The mean of the full scale was 34.6 (range = 13-48; SD = 9.9). The mean score of 
the aptitude subscale was 16.9 (range = 6-24; SD = 5.8), and individual item means 
ranged from 3.66 to 4.84 on the response option set that ranged from 1-6. These scores 
indicate a trend toward confidence in self-rated numerical aptitude. The mean of the 
preference subscale was 17.8 (range = 4-24; SD = 4.8), with individual item means 
ranging from 4.06 to 4.81 (response options ranged from 1 to 6), suggesting an overall 
preference for numerical information over verbally descriptive information. A Pearson 
product moment correlation was conducted to determine the degree of relationship 
between the full scale and the subscales of the SNS. There was a significant and positive 
correlation between the full scale of the SNS and the aptitude subscale (r = .94, p < .001) 
as well as the preference subscale (r = .80, p < .001). There was also a significant 
correlation between the aptitude subscale and the preference subscale of the SNS (r = .55, 
p = .002).  
 To examine the construct validity of the SNS in an oncology setting, a Pearson 
product moment correlation was conducted to determine the degree of relationship 
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between scores on the SNS (and its two subscales) and scores on the 11-item Numeracy 
Scale. Scores on the full scale of the SNS were significantly and positively correlated 
with the 11-item Numeracy Scale (r = .40, p = .03). Scores on the aptitude subscale of the 
SNS and the 11-item Numeracy Scale were also positively and significantly correlated (r 
= .44, p = .01); however, the preference subscale of the SNS was not significantly 
correlated with the objective numeracy scale (r = .28, p = .13).  
Numeracy, Conflict, and Regret 
To address the second study aim, the relationships between subjective and 
objective numeracy and measures of TDM (e.g., decision regret and decisional conflict) 
were also explored. The mean score on the DRS was 14.2 (range = 0-50; SD = 15.5), 
suggesting that the average participant in this study reported little regret. Descriptive 
statistics for the DCS showed a similar trend, with a mean of 31.6 (range = 16-52, SD = 
8.1). This indicates that few participants were reporting decisional conflict. 
A Pearson product moment correlation was used to test the hypothesis that scores 
on the SNS and 11-item Numeracy Scale would be significantly and negatively correlated 
with decision regret See Table 2. Results showed no significant relationship between the 
full scale SNS and the DRS (r = -.06, p = .78). Analysis of the subscales of the SNS also 
found no significant relationship between either the SNS aptitude subscale (r = -.04, p = 
.81) or the SNS preference subscale (r = -.06, p = .74) and the DRS. Finally, there was no 
significant relationship between the 11-item Numeracy Scale and the DRS (r = .26, p = 
.15).  
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Table 2 
Correlations Between SNS, 11-item Numeracy Scale, and DRS 
________________________________________________________________________ 
Measure           DRS 
______________________________________________________________________________ 
SNS Full Scale       -0.17 
 SNS Aptitude       -0.04 
 SNS Preference        -0.29 
 
11-item Numeracy Scale        0.26 
______________________________________________________________________________ 
Note: * p < .05; ** p < .01  
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A Pearson product moment correlation was also used to test the hypothesis that 
scores on the SNS and 11-item Numeracy Scale would be significantly and negatively 
correlated with decisional conflict. See Table 3. There was no significant relationship 
between the full scale SNS and the full scale of the DCS (r = -.13, p = .50). Analysis of 
the subscales of the SNS also found no significant relationship between either the SNS 
aptitude subscale (r = -.27, p = .49) or the SNS preference subscale (r = -.06, p = .77) and 
the full scale DCS. Finally, there was no significant relationship between the 11-item 
Numeracy Scale and the full scale of the DCS (r = -.03, p = .87).  
The relationship of the subscales on the DCS to scores on the SNS and 11-item 
numeracy scale were also explored with a Pearson correlation. See Table 3. None of the 
subscales on the DCS were significantly correlated with scores on the full scale SNS 
(uncertainty: r = -.19, p = .31; factors contributing to uncertainty: r = -.09, p = .60; 
effective decision making: r = -.10, p = .92). Similarly, none of the subscales on the DCS 
were significantly correlated with scores on the SNS aptitude subscale (uncertainty: r = -
.15, p = .42; factors contributing to uncertainty: r = -.13, p = .49; effective decision 
making: r = -.02, p = .93) or the SNS preference subscale (uncertainty: r = -.14, p = .46; 
factors contributing to uncertainty: r = -.02, p = .93; effective decision making: r = -.56, 
p = .77). Additionally, none of the subscales on the DCS were significantly correlated 
with scores on the 11-item Numeracy Scale (uncertainty: r = -.04, p = .82; factors 
contributing to uncertainty: r = -.02, p = .90; effective decision making: r = -.01, p = .96). 
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Table 3 
Correlations Between SNS, 11-item Numeracy Scale, and DCS 
______________________________________________________________________________________ 
Measure DCS       DCS Uncertainty      DCS Fact. Uncertainty        DCS Eff. DM  
______________________________________________________________________________ 
SNS Full Scale               -0.18           -0.20   -0.14 -0.10 
 SNS Aptitude            -0.13              -0.15  -0.13          -0.02 
  
 SNS Preference -0.18  -0.18 -0.13         -0.16         
  
 
11-item Numeracy  -0.03 -0.04 -0.02 -0.01 
Scale                   
______________________________________________________________________________ 
Note: * p < .05; ** p < .01  
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Qualitative Data Analysis 
 Numerical Experiences and Preferences 
 With regard to the third study aim, both questionnaire and interview data explored 
patient perceptions of their numerical aptitude and preference for receiving numbers in a 
treatment consultation. For ease of understanding, the results for the third aim will 
described according to the categories of themes identified in the interview data: Aptitude, 
Preferences, and Potential Barriers. Frequencies and percentages of the identified themes 
can be found in Table 3. When applicable, each category will be described by first 
presenting the results of the quantitative content analysis followed by the relevant themes 
and representative quotes. Consistencies and discrepancies between the interview data 
and the questionnaire data will be outlined in the discussion section. 
Numerical Aptitude 
 Results from the quantitative content analysis showed that the majority of 
participants interviewed (60%) indicated that numbers were used during their treatment 
consultation. In addition, interview data revealed that 75% of respondents reported that 
they understood numbers when used to describe treatment information, while 10% 
reported that they were not confident in their ability to understand numbers used during 
treatment consultations. See Table 4.  
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Table 4  
Quantitative Content Analysis (N = 20) 
________________________________________________________________________ 
           
Frequency % 
________________________________________________________________________ 
Did your oncologist use numbers during  
your treatment consultation? 
              
 Yes    60   12  
 No                            40  8 
 Unsure  0  0 
 Unclear response  0  0 
 
Would you prefer your doctor to use numbers  
to talk about treatment options?    
 Yes  65  13 
 No  25  5 
 Unsure  5  1 
 Unclear response           5  1 
 
Do you think you are able to understand 
numbers used to talk about treatment options?       
 Yes  75 15  
 No  10  2 
 Unsure  0 0 
 Unclear response           15  3 
 
________________________________________________________________________ 
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There were a number of themes identified in the interview data when following 
the quantiative content analysis with a qualitative descriptive approach, listed in Table 
5.The Aptitude category was represented by the theme Misunderstanding of Numerical 
Principles. This theme was defined as a statement demonstrating a misunderstanding of 
statistical or numerical principles; exemplified by the following comment made by a 
participant in response to the question: “So what do you think about using numbers like 
that to discuss treatment options?” 
“I think it’s good… if somebody tells you, well you’re going to live 5 years or say 
1 in 5 people survive 5 years after they were diagnosed with this type of cancer.  
You know that’s giving you a life expectation of 5 more years.” 
 
This statement indicated that the participant assumes that they are included in the 
“1 in 5” statistic, which seems to impact the individual’s understanding of their own 
prognosis and disease course. Another participant’s statement clearly represents the 
confusion that can occur when providing statistics in a clinical setting: 
“…Cuz it seems to me like there was an 80% mentioned, but I’m like well what 
does that mean? 80% I’ll die?... Cuz I mean I knew enough to know that if I was 
hearin that if it was 20% chance I’ll live…or is it 80% that I’ll die?” 
 
 A misunderstanding of basic statistical probabilities regarding risks and benefits 
of treatment likely significantly influences how an individual makes decisions about their 
treatment. The statements made by multiple participants in the interview indicated that 
these misunderstandings might be relatively common. 
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Table 5 
Identified Themes in Patient’s Experiences of Numerical Treament Information (N = 20) 
________________________________________________________________________ 
Theme     % mentioned Frequency   # of times 
  of theme     mentioned 
______________________________________________________________________________ 
Aptitude                             
 Misunderstanding of Numerical Principles                   10                      2                         3 
  A statement demonstrating a  
  misunderstanding of numerical 
   or statistical principles.   
Preferences 
 Need for Numbers              45        9   13 
A belief that percentages and odds  
about treatment reduce ambiguity and  
are necessary in order to make a  
treatment decision.          
 Distrust of Statistics/Provider              15                     3  5 
  An opinion that statistics can  
  be manipulated to persuade, resulting 
   in distrust of numerical  
  treatment information.       
 Numerical Anxiety              10  2     2 
A statement by a participant  
indicating that they prefer not to receive 
numerical treatment information due to  
a tendency to dwell/worry about the  
numbers.   
 Trust in Physician   10  2  4 
  Statement demonstrating trust that  
  physicians will provide necessary  
  information.    
 Tailored Treatment Information   25  5  7 
 Indication that treatment information  
 must be relatable and should be adjusted  
 to patient preferences, education, or  
 level of understanding.    
Potential Barriers 
 Passive Avoidance of Numbers           20  4  7 
  
 A statement indicating that a participant 
  ignored or did not pay attention to 
  numerical treatment information.     
 Religious Faith   10                      2  4 
  A belief that God ultimately decides  
  whether a person will be cured of cancer,  
  making it unnecessary to receive numbers/ 
  statistics about treatment information. 
________________________________________________________________________ 
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Numerical Preference 
When interviewed, 65% of participants indicated that they preferred the use of 
numbers in a treatment consultation, while 25% reported that they did not want numbers 
used to discuss their treatment options or decision. Of those that reported they preferred 
the use of numbers in a treatment consultation, 66% reported that their oncologist did use 
numbers to discuss treatment options.   
Several themes identified in the qualitative interview data provide further insight 
into patient preferences for receiving numerical treatment information. The Preference 
category was represented by the following themes: Need for Numbers, Distrust of 
Statistics/Provider, Numerical Anxiety, Trust in Physician, and Tailored Treatment 
Information. See Table 3 for frequencies and percentages.  
The preferences of those that wished to receive numerical treatment information 
were represented by the theme Need for Numbers. This was defined as a belief that 
percentages and odds about treatment reduce ambiguity and are necessary in order to 
make a treatment decision. Some participants stated that numbers were helpful in gaining 
an idea of what to expect. When asked if the use of numbers in the treatment consultation 
was helpful, one participant responded: 
“It was very helpful for me. It helped me sure because it gives you more of an 
idea what lays ahead.” 
Others discussed the necessity of numbers for weighing treatment options.  
 “I think it’s a good thing. Basically it’s, otherwise you probably could go into it 
just very blindly going, okay this is just going to fix everything. So I prefer the 
numbers to know that you know you if have a 50/50 which is better than you know 
40/60 or whatever. You know and so yeah, I prefer the numbers to you know just 
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blindly going along and going, okay you know we’ll just see where it takes us you 
know.” 
 
“I think that’s a good way, I think that’s a good way to talk about it because you 
know to me you need to know what we’re talking about; out of 100 people, how 
many people really survive the surgery, how many people really survived before 
they got to the treatment. So I think that’s a good way of, for me to describe in 
numbers.” 
 
Participants with a preference for numbers also indicated that numbers can help reduce 
ambiguity.  
“I mean to me it’s much clearer to say you know you have a 80% survival chance 
as opposed to saying you know you have a very good survival chance because you 
know to me that might be 51%.” 
 
“…I don’t think words can do it justice. There’s a big difference between saying, 
there’s a good chance of something happening and saying, there’s only a 1% 
chance; but I’m comfortable with numbers. So I just, to me if you said, there’s a 
good chance of this happening, it means nothing to me. If you say, there’s a 1% 
chance or 1/2 % chance or a 5, then it means something to me.” 
 
 The views of participants who stated that they did not wish to receive numerical 
treatment information were represented by two themes: Distrust of Statistics/Provider, 
and Numerical Anxiety. Distrust of Statistics/Provider was defined as an opinion that 
statistics can be manipulated in order to persuade, therefore, numerical treatment 
information provided by the physician cannot be fully trusted. A number of participants 
cited distrust of how numerical information can be manipulated as a reason to not receive 
numerical treatment information.  
“Yeah, but that’s just me because again, statistical information, it all depends on 
how you look at it you know…I don’t think he was trying to you know like be 
dishonest with me or whatever but you can use statistics any old way you want to 
I mean you know…Well it’s the source I question, the numbers I don’t.” 
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 These individuals expressed a preference to receive qualitative treatment 
information based on a distrust of how numerical information could be manipulated in 
order to persuade them to accept a particular treatment.  
This preference for receiving qualitative descriptions over numerical treatment 
information was also explained by anxiety over numbers. Several participants described 
feeling anxious when given treatment information in numerical terms. This was 
represented by the theme Numerical Anxiety, which was defined as a preference not to 
receive numerical treatment information due to a tendency to dwell or worry about the 
numbers. When asked if they would prefer receiving treatment information numerically, 
one participant responded: 
“No, I would not, I would not prefer that because you’d always have those 
numbers in your mind and you would always dwell on that 10% or 20% that it 
could reoccur and I don’t think it’s good personally I don’t, no.” 
 
 The previous themes represented specific preferences for receiving numerical 
treatment information. The remaining themes reflected an overall acknowledgment of the 
importance of adequate patient-physician communication and the need to communicate 
preferences for receiving treatment information to their physician. This acknowledgement 
was represented by two themes, Trust in Physician and Tailored Treatment Information. 
The theme Trust in Physician was represented by a statement that the physician was 
trusted to provide the necessary treatment information. As one participant explained,  
“I would prefer to know, and I think that’s something that involves once again 
trust because I could just let my doctor know you know, this is something that I 
would like to know. You see I think this is a back and forth between the doctor and 
a patient you know.  Don’t keep any secrets from me or there are things that I 
would rather not know you know. I think that should be a personal individual 
decision.”  
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 Other participants recognized the need for physicians to tailor the information 
according to the patient’s preferences and level of understanding, as reflected by the 
theme Tailored Treatment Information.  
“This is going to sound elitist but I think a balanced use of percentages or 
numbers can be helpful but if you’re dealing with a, if you’re dealing with a 
person who is, whose economic or, and/or education background is significantly 
limited. Then I, then I think you may use those but don’t assume that it’s going to 
say much… 
 
 Because there would certainly be plenty of people economically and 
academically challenged who have a whole lot of saviness and common sense but 
I think, yeah I think some of it really depends and I don’t know how a doctor 
makes this decision. I think some of it depends on the doctor’s initial assessment 
of the patient’s world view.” 
 
 These last two themes in the Preferences category represent a more 
comprehensive view of the treatment communication process that goes beyond whether 
or not patients prefer receiving a particular type of information and highlights the 
importance of communication between patients and providers.  
Potential Barriers to Patient Engagement 
 
 Two themes were identified in the interview data that were distinct from 
numerical aptitude and preference and were not represented in the quantitative data. 
These concepts may act as additional barriers in obtaining informed consent. These 
themes, Passive Avoidance of Numbers and Religious Faith, appear to represent intrinsic 
patient characteristics or beliefs that may limit patient engagement in the TDM process. 
 Passive Avoidance of Numbers was defined as a statement that the patient ignored 
or did not pay attention to numerical treatment information provided to them.  
“…I guess that didn’t matter at the time or it didn’t, I don’t know, it’s just like…I 
don’t, I remember something about the numbers but I don’t remember a whole lot 
about it; it’s just like it went over my head or wasn’t that important. Have you 
ever done that where you, somebody says? I don’t know if you’ve been in a 
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situation like that but it’s like you’re, you just want to hear a certain part of what 
he’s saying but you don’t, you don’t really care about the odds of it all.” 
 
When asked if they preferred to receive odds or percentages regarding their 
treatment, these patients also indicated that they did not want to be given this 
information: 
 
“No, I don’t think, I don’t like to think about something happening.” 
 
“…he’s used numbers to say a certain percentage of people do this treatment and 
your odds are 50/50 or 60/40 or you know; I don’t pay attention to numbers, I 
really don’t.” 
 
The final theme identified from the interview data was Religious Faith. This 
theme was defined as a belief that God ultimately decides whether a person will be cured 
of cancer, making it unnecessary to receive numbers/statistics about treatment 
information. This belief was endorsed by several participants that completed the 
interview.  
”No, numbers don’t mean a great deal to me. It’s just, you know if it works, if it 
works; if it doesn’t, it doesn’t. There’s, well how can I explain this? To me, 
there’s no downside to this. There’s an inconvenience factor…Either one or two 
things are going to happen; either the doctors are going to come up with a cure 
for it and I’ll praise God for that because it’ll be a testament to God’s greatness 
or they’re not going to come up with a cure for it and one of these days I’m going 
to go home. 
 
And when I first got diagnosed, I came home and I went to my prayer spot and I 
started praying. And pretty soon I wasn’t praying; I was just mad, and I was 
yelling at God, well just blamed Him for everything that ever went wrong with my 
life. And you take this for what it’s worth but I heard a voice and called me by 
name and it said, you know, I can help you but you have to give it to me, you can’t 
do it by yourself. And I got back down on my knees and I gave it to God that very 
day and I’ve been at peace with it ever since. So yeah, numbers, yeah they don’t 
mean that much to me.” 
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Exploratory Analysis 
 
A number of exploratory analyses were conducted to examine questions that 
resulted from the initial investigation of the primary aims. These analyses are reported in 
the following section.  
 11-Item Numeracy Scale 
The mean score on the 11-item Numeracy Scale was 8.06 (range = 0-11; SD = 
2.5). Only 12.5% of participants correctly answered all items on this scale, a significant 
difference between this sample and the samples used to validate this instrument. In the 
validation study, (Lipkus, Samsa, & Rimer, 2001) 29 to 34% of the samples answered 
every item correctly. To determine which items were particularly difficult for 
participants, frequencies of correct and incorrect responses were calculated. Participants 
seemed to struggle most with questions regarding the calculation of a percentage chance 
that an arbitrary event would occur. For example, only 28% of the sample correctly 
answered a question that required a percentage calculation based on a 1 in 1,000 chance. 
Encouragingly, however, our sample performed best on questions that were specific to a 
medical context. Nearly all (94%) participants correctly identified the biggest risk of a 
disease in a 1 in n format, and a percentage format (97%). Most participants (88%) also 
correctly calculated person B’s percent risk of a disease if it was doubled that of person 
A’s, and 91% also successfully calculated the number of people that would get a disease 
based on a percentage.  
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Table 6 
Percentage of correct responses on the 11-item Numeracy Scale (N = 32) 
________________________________________________________________________ 
Question         %       Frequency 
________________________________________________________________________  
         
In the Big Bucks Lottery, the chance of winning a $10.00 prize   62.5  20 
is 1%. What is your best guess about how many people would  
win a $10.00 prize if 11,000 people each buy a single ticket to  
BIG BUCKS? 
Answer: 10 persons out of 1,000 
 
In the Acme Publishing Sweepstakes, the chance of winning a  28.1  9 
car is 1 in 1,000. What percent of tickets to Acme Publishing  
Sweepstakes win a car? 
Answer: 0.1% 
 
Which of the following numbers represents the biggest risk of  93.8  30 
getting a disease? (1 in 100, 1 in 1,000, 1 in 10?) 
Answer: 1 in 10 
 
Which of the following numbers present the biggest risk of  96.9  31 
getting a disease? (1%, 10%, 5%?) 
Answer: 10% 
 
If Person A’s chance of getting a disease is 1% in ten years,   87.5 28 
and person B’s risk is double that of A’s, what is B’s risk? 
Answer: 2% 
 
If Person A’s chance of getting a disease is 1 in 100 in ten years,  59.4  19 
and person B’s risk is double that of A’s, what is B’s risk? 
Answer: 2 of 100 
 
If the chance of getting a disease is 10%, how many people would  90.6  29 
be expected to get the disease out of 100? 
Answer: 10 
 
If the chance of getting a disease is 10%, how many people would  90.6  29 
be expected to get the disease out of 1000? 
Answer: 100 
 
Imagine that we rolled a fair, six-sided die 1,000 times. Out of  46.9  15 
1,000 rolls, how many times do you think the die would come up  
even? (2, 4, or 6)? 
Answer: 500 out of 1,000 
 
If the chance of getting a disease is 20 out 1,000, this would be  78.1  25 
the same as having a ___% chance of getting the disease.  
Answer: 20 
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The chance of getting a viral infection is .0005. Out of 10,000 people  71.9  23 
about how many of them are expected to get infected? 
Answer: 5 people 
__________________________________________________________________________ 
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 Numeracy and TDM Measures 
 The lack of significant relationship between the numeracy scales and the TDM 
measures led to an examination of specific items on the Decisional Conflict Scale that 
may have better explained this relationship. The Decisional Conflict Scale contains items 
that are specific to having enough information about treatment options and may be more 
likely to have a positive relationship with objective and subjective numeracy. Therefore, 
a Pearson Product Moment Correlation was used to examine two items from the DCS: “I 
feel I know the risks and side effects of my treatment options” (Item 1) and “I need more 
information, advice and information about the choices” (Item 2) and their relationship 
with the SNS and the 11-Item Numeracy Scale. 
 Item 1 was not significantly correlated with the SNS (r = .04, p = .85) or the 11-
Item Numeracy Scale (r = .05, p = .78). Similarly, Item 2 was not significantly correlated 
with the SNS (r = -.18, p = .33) or the 11-Item Numeracy Scale (r = -.29, p = .11). 
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Chapter Four: Discussion 
 Recent literature examining health numeracy and literacy has highlighted the 
difficulty that many patients have with understanding complex numerical treatment 
information (Garcia-Retamero & Galesic, 2010; Nelson et al., 2008; Peters, Hibbard, 
Slovic, & Dieckmann, 2007; Reyna & Brainerd, 2007; Reyna, Nelson, Han, & 
Dieckmann, 2009). Simply providing information to patients does not necessarily 
translate to comprehension and ability to use the information provided (Peters, Hibbard, 
Slovic, & Dieckmann, 2007). In order for patients to make informed decisions about their 
oncological care, it is necessary to identify aspects of the TDM process that can be 
simplified and improved. This is of particular concern in populations of cancer patients 
that typically make multiple treatment decisions over the course of their disease (e.g., 
follicular lymphoma). 
The purpose of this study was to explore numeracy and patient experience with 
numbers in a sample of follicular lymphoma patients using a mixed methods approach. 
The first aim of this study was to examine the psychometric properties of the Subjective 
Numeracy Scale and explore the construct validity of subjective numeracy in an oncology 
setting. The second aim of this study was to examine the relationship between subjective 
and objective numeracy and measures of TDM. Finally, the third aim of this study 
utilized qualitative interview data to provide additional information about numeracy by 
exploring and describing 1) patient reports of the use of numbers in the clinical 
consultation and perceived ability to work with numbers and 2) patient perception of and 
preference for the use of numbers in TDM.  
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Summary and Interpretation of Findings 
Properties of the Subjective Numeracy Scale 
The SNS was developed to use as a proxy for patient’s objective level of 
numerical ability (Fagerlin et al., 2007) but prior to this study had not been validated on a 
sample of cancer patients. Reliability analyses demonstrated that the SNS has adequate 
internal consistency reliability in this sample. In addition, reliability analyses of the 
subscales suggested that the items on the aptitude subscale may be reduced without 
compromising reliability in order to reduce patient burden. The results of a Pearson 
product moment correlation in this sample indicated a medium to large correlation 
between patient scores on the full SNS and scores on the 11-item Numeracy Scale 
(Lipkus, Samsa, & Rimer, 2001). Analyses indicated a similar relationship between the 
aptitude subscale of the SNS and the 11-item Numeracy Scale. However, there was no 
statistically significant relationship between the preference subscale of the SNS and the 
11-item Numeracy Scale.  
The magnitude of the correlation between subjective and objective numeracy in 
this sample is lower than the large effect found in the original validation sample of the 
SNS (Fagerlin et al., 2007). In addition, no significant correlation was found between the 
preference subscale of the SNS and the 11-item numeracy scale. The SNS was designed 
with two subscales that represent two distinct constructs, aptitude and preference. The 
results from this sample indicated that the preference subscale had no utility as an 
indicator of objective numerical ability. The authors of the SNS suggest that this measure 
replace traditional measures of objective numeracy (Fagerlin et al., 2007). Based on the 
examination of the psychometric properties of this scale in this study, it may be 
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premature to conclude that the full scale of the SNS should be used as a replacement for 
objective numeracy measures. 
Further analyses of the SNS in conjunction with the interview data and the 11-
item Numeracy Scale raised additional concerns about the use of self-rated numerical 
ability as a replacement for the measurement of objective numerical ability. Almost all 
participants interviewed reported that they were able to understand the numerical 
information used by their oncologist during a treatment consultation. In addition, the 
scores on the aptitude subscale of the SNS indicated that nearly half of participants feel 
they are good or extremely good at calculating simple mathematical problems such as 
percentages and fractions. However, when compared to the scores on the 11-item 
Numeracy Scale, very few participants correctly answered all the questions and almost 
one-quarter of the sample correctly answered six or fewer questions. Additionally, these 
measures were completed by mail. Although participants were not provided instructions 
on the use of a calculator, it may be assumed that several participants used a calculator to 
aid in responding, therefore these results may be an overestimate of numerical ability in 
this sample. Finally, the numerical information provided in an actual treatment 
consultation is likely more complex than that represented in the 11-item Numeracy Scale 
(Peters, Hibbard, Slovic, & Dieckmann, 2007). The results from this study may then be 
considered a “best case scenario” for patient understanding of basic numerical operations. 
This discrepancy between patient’s perception of their numerical ability and their actual 
understanding of numerical information in a treatment consultation has significant 
implications for the utility of subjective numeracy ratings in clinical practice. 
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Results from this study suggest that further research is needed before the 
measurement of subjective numeracy is used as a proxy for objective numeracy in a 
cancer population. A recent study by Galesic and Garcia-Retamero (2010) found that the 
SNS successfully differentiated between participants who scored very low and very high 
on an objective numeracy measure. It was not possible to do a similar comparison in this 
study, for two reasons: Most participants in the current study rated themselves highly on 
the SNS, leaving little variation in scores; and few participants scored very high on the 
11-item Numeracy measure. As this is the first study examining this relationship in a 
cancer population, conclusions on the use of the SNS in clinical practice cannot yet be 
drawn. There are a number of concerns about using a subjective numeracy measure in 
place of an objective numeracy measure in this population prematurely. The reduced 
capacity for adequate decision making (Consedine & Moskowitz, 2009; Diefenbach et 
al., 2008; Fischoff, 1999; Rini et al., 2009) and the potentially life threatening 
consequences of an uninformed treatment choice in the oncological setting likely 
outweigh the time saving benefit of omitting measures of objective numeracy in the TDM 
process. Patients with lower numeracy have more difficulty using numerical information 
to make a decision than those with higher numeracy (Peters, Hibbard, Slovic, & 
Dieckmann, 2007; Schwartz, Woloshin, Black, & Welch, 1997). Accurately assessing 
numeracy is a first step in providing interventions to patients who will have more 
difficulty understanding numerical treatment information. The results from this study 
indicated that patients in this sample significantly overestimate their actual numerical 
ability, suggesting that caution is needed when relying solely on a subjective numeracy 
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measure to assess a patient’s ability to understand the risks and benefits of various 
treatment options.  
Numeracy, Conflict, and Regret 
The second aim of this study was to investigate the relationship between 
subjective and objective numeracy and measures of decision conflict and regret. There 
have been no previous studies that have examined the potential consequences of low 
numeracy on the TDM experience. There were no significant relationships between 
subjective and objective numeracy and patient reported conflict and regret. Few patients 
in this sample reported high levels of conflict and regret regarding their most recent 
treatment decision, limiting the ability to detect significant relationships between the 
constructs. Additionally, in this sample, patients had a tendency to overestimate their own 
numerical ability. It is possible that patients’ perceptions of their understanding of the 
treatment information they are given is more significant for decision conflict and regret 
than objective understanding. For example, if patients expressed confidence in their 
ability to understand numerical treatment information, it is unlikely that they would 
report high levels of conflict or regret about their treatment decision due to confusion or 
misunderstanding of the information they were given. Patients that did report conflict and 
regret may have done so for reasons unrelated to their subjective or objective 
understanding of numerical treatment information.  
Numerical Experiences and Preferences 
The final aim of this study was to further explore patients’ experiences with 
numbers in a treatment consultion, perceived numerical aptitude, and preferences for 
numbers during the TDM process using qualitative interviews. Overall, the interview data 
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supported the results found in the quantitative data and provided further insight into the 
role that patient preferences and beliefs may play in the treatment consultation. The 
qualitative data provided a more comprehensive view of patient experiences during the 
treatment consultation. This data supported concerns regarding patient understanding of 
numerical treatment information and also provided important information about the 
varied needs and preferences of patients when receiving treatment information. Finally, 
this data also identified potential barriers for TDM engagement and informed consent that 
may be separate from the ability for patients to comprehend the information provided to 
them.  
Almost all patients reported that numbers were used during their treatment 
consultation. No recent studies were found regarding the prevalence of numerical 
information given in oncological treatment consultations. However, a 1998 study 
investigating the use of quantitative estimates of prognosis in adjuvant breast cancer 
treatment (Ravdin, Siminoff, & Harvey, 1998) found that only 39% of women reported 
the use of these estimates. There are a number of reasons why these reports of number 
use may vary, such as the increase in patient participation in TDM since 1998. Despite 
the lack of prevalence research in number use in oncology treatment consultations, these 
data suggest that a substantial number of cancer patients are receiving treatment 
information in a quantitative format. Communicating information about treatment often 
necessitates the use of numbers, such as the percentage of patients who survive for five 
years, the magnitude of effectiveness of different treatments, and probability that the 
patient will experience side effects (Lipkus & Peters, 2009; Peters, Hibbard, Slovic, & 
Dieckmann, 2007; Reyna, Nelson, Han, & Dieckmann, 2009; Smith, 2003). The high 
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proportion of patients in this study who encountered the use of numbers when describing 
treatments highlights the need for further investigation on the use of numbers in treatment 
consultations and its impact on how patients make decisions.  
Similar to the results found on the aptitude subscale of the SNS, most patients 
reported that they were confident in their ability to understand numbers used when 
discussing treatment information. However, this perceived numerical aptitude was 
inconsistent with actual numerical performance as measured by the 11-item Numeracy 
Scale. Very few participants answered all questions on this scale correctly, and a 
substantial portion answered less than six questions correctly. These results are consistent 
with a recent study using an adapted version of the Lipkus, Samsa, and Rimer (2001) 
scale. A study by Galesic & Garcia-Retamero, 2010 found that a sample of German and 
United States citizens correctly answered two-thirds of the items on a 9-item version of 
this scale. As in this study, these questions required patients to perform basic 
mathematical opeations, such as calculating a percentage. As noted above, actual 
treatment information is often much more complex than that represented in objective 
numeracy measures. For example, in situations where it is uncertain what the best 
treatment is, patients may be requried to calculate differences between therapies and 
make inferences about the best choice based on that information (Peters, Hibbard, Slovic, 
& Dieckmann, 2007). The interview data also contained examples of misunderstandings 
of basic numerical principles when patients described the information given to them by 
their physician, such as the meaning of a “1 in n” statistic. This overstimation of 
numerical ability may have negative consequences for patients. Patients may assume they 
understand the information provided, and therefore not ask questions clarifying 
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comparisons between treatments. Physicians may also perceive that these patients 
comprehend the information and not ask follow-up questions that check for 
understanding. Ultimately, this confidence in numeracy may result in patients making 
treatment decision based on inaccurate or incomplete understanding of the risks and 
benefits involved. 
Most interviewed participants reported that they had a preference for receiving 
numbers to describe treatment information. This was consistent with an overall trend 
toward a preference for numerical information on the preference subscale of the SNS. 
Other studies using cancer populations have found that a significant proportion of 
patients prefer the use of numbers to describe treatment information over the use of 
qualitative descriptors (Lobb et al., 1999; Mazur, Hickam, & Mazur, 1999). This is 
consistent with the findings of the current study. One item on the SNS preference 
subscale asked if participants had a preference for describing a chance of something 
happening in words or numbers. On this item, the mean response was 4.4 out of 6, with a 
response of 6 indicating a strong preference for the use of numbers. In addition, thirty-
five percent of participants indicated that they would “always” prefer a chance 
description in numbers, while only 16% reported that they would “always” prefer this 
description in words.  
The participants in this study that elaborated on their preference for the use of 
numbers described them as necessary for understanding treatment risks and benefits and 
reducing ambiguity. Other studies examining patient preferences in a cancer setting have 
not specifically queried patients about why they preferred the use of numbers. However, 
studies of individuals in the general population provide evidence that numbers are more 
53 
 
precise and accurate than qualitative descriptors or graphs (Gurmankin, Baron, & 
Armstrong, 2004; Lipkus, 2007; Nakao & Axelrod, 1983; Sutherland, 1991), and some 
studies have suggested that individuals trust quantitative information more (Wallsten, 
Budescu, Zwick, & Kemp, 1993).  
Alternatively, the smaller group of participants that did not wish to receive 
treatment information in a numerical form reported two reasons for this preference. The 
most commonly mentioned concern about numerical information included the possibility 
of numbers and statistics being manipulated in order to persuade. Participants described 
distrust of numerical treatment information based on the idea that it could be presented in 
a way that led the patient to a particular treament choice (presumably, the physician’s 
preference for treatment). There is evidence that physicians may use information to 
persuade toward their own preferred treatment choice (Lelie, 2000). Of particular concern 
in the oncology setting, a study of radiation oncologists and urologists suggests that 
physicians have a bias toward their specialty and may make recommendations or the 
treatment they deliver despite lack of support from randomized clinical trials (Fowler, 
Collins, Albertson, Zietman, Elliott, & Barry, 2000). However, individuals lower in 
numeracy tend to view numerical information given by their physicians as less 
trustworthy (Gurmankin, Baron, & Armstrong, 2004), making this concern an important 
one to directly address when presenting treatment information to patients.  
Patients also cited numerical anxiety as a reason they did not prefer the use of 
numbers in treatment consultations. Patients described the use of numbers resulting in 
enhanced rumination about particular percentages, such as the risk for recurrence. This 
anxiety about numerical treatment information may be a result of difficulty understanding 
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the meaning of the numbers given, as less numerate people are more likely to be 
influenced by other sources of information, such as emotions, mood, and distrust of 
physicians (Peters, Hibbard, Slovic, & Dieckmann, 2007; Smith, 2003). There are a 
number of reasons why patients may not wish to receive numerical treatment 
information, which may reflect valid concerns about the quality and clarity of the 
information they are given. However, these reasons may also be masking low numeracy 
and discomfort for numbers, which further supports an argument for the assessment of 
numeracy prior to treatment consultations.  
The remainder of the data regarding preferences was not specific to the use of 
numbers and generally reflected the need for adequate communication between patients 
and providers. Some patients mentioned trust that their physician would give them the 
information they needed to make a good decision, reflecting a more paternalistic view of 
TDM. This theme may encompass those patients who wish to have a less active role in 
the TDM process. Finally, a quarter of participants described the importance of treatment 
information being tailored to each patient based on ability level. This was the second 
most commonly occurring theme in the data, suggesting that patients wish the treatment 
consultation process to be individually fitted to them. This idea is consistent with 
research evidence that tailored messages are more likely to be read and remembered, may 
enhance personal relevance, and promote effortful processing (Hawkins, Kreuter, 
Resnicow, Fishbein, & Dijkstra, 2008; Kreuter & Wray, 2003; Petty & Cacioppo, 1981).  
Lastly, the interview data provided important information that may cause 
difficulties for shared decision making and obtaining informed consent. Several patients 
mentioned an avoidance of numbers by ignoring or “not paying attention” to the 
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numerical information given to them. These patients appeared to be describing a 
tendency to avoid numbers in order to keep from thinking about their disease or their 
odds of recovery. It is possible that similar to numerical anxiety, avoiding discussion of 
numbers in the treatment consultation may be indicative of low numeracy and difficulty 
comprehending numerical treatment information. However, this may simply be an 
indication that a more passive role in the decision making process is desired. Finally, two 
patients mentioned that their belief in God made receiving numerical treatment 
information unnecessary. They described a feeling that God will decide if they will live 
or die, therefore, it was not necessary for them to attend to the treatment information 
given to them. A study examining the attitudes of lung cancer patients and their 
physicians found that highly religious individuals rate their faith as very important in the 
TDM process, even more highly than whether the treatment would cure their disease 
(Silvestri, Knittig, Zoller, & Nietert, 2003). Research suggests that religious beliefs may 
have positive benefits for cancer patients, such as improved coping and well-being, 
although the methodological rigor of studies measuring this construct has been 
questioned (Howsepien & Merluzzi, 2009; Visser, Garssen, & Vingerhoets, 2009). 
However, there may be negative outcomes as well, including the idea of fatalism, or that 
one’s fate is controlled by God, which has been linked to lower rates of screening and 
treatment (Powe & Finnie, 2003). This particular theme seems to be a reflection of this 
concept, and therefore raises some concerns regarding the impact of this belief on shared 
decision making and obtaining informed consent for treatment.  
The interview data collected in this study provides a more in-depth understanding 
of how patients experience the TDM process regarding quantitative information. 
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Although patients may report confidence in their ability to understand the numerical 
treatment information given to them, this may not be reflected in their accuracy of 
understanding. Additionally, most patients appear to find numerical treatment 
information important, but many may lack the skills needed to condense this information 
and apply it to their own needs and preferences. While the majority of patients in this 
study preferred to receive numerical treatment information, there is also a significant 
proportion that did not. Reasons for this preference varied, but may be an indicator of low 
numeracy or a desire for a more passive role in the TDM process.  
Limitations 
 Limitations of this study should be noted. First, the study sample was relatively 
small, potentially limiting the statistical power to detect statistically significant effects. It 
is also not possible to draw firm conclusions from a sample of this size. In addition, this 
study was homogenous. All but one participant was Caucasian, most participants resided 
in rural areas of Kentucky, and most participants identified as having a Christian religious 
affiliation. This limits the ability for these study results to be broadly applied to the 
general population. In addition, the educational level of the participants was not assessed. 
As a result, it was not possible to examine the relationship between educational level and 
numerical ability. Finally, participants were asked to discuss their most recent treatment 
decision. The length of time from this decision to study enrollment varied widely 
between participants. This may have impacted the accuracy with which patients were 
able to report on their experience.  
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Clinical Relevance 
 The sample size of the current study was small, limiting the ability to make strong 
recommendations based exclusively on these results. Despite the small sample of this 
study, results are consistent with recent literature reviews on numeracy and TDM, 
supporting the following conclusions and recommendations.  
This study supports previous research identifying the difficulty that the general 
population has with understanding basic numerical calculations, (Fagerlin et al., 2007; 
Galesic & Garcia-Retamero, 2010; Lipkus, 2007; Reyna, Nelson, Han, & Dieckmann, 
2009; Peters, Hibbard, Slovic, & Dieckmann, 2007; Weinfurt et al., 2005) and provides 
strong evidence of the tendency to overestimate numerical ability. Other researchers have 
pointed out that physicians tend to overestimate how much patients understand 
(Gattellari, Butow, Tattersall, Dunn, & MacLeod, 1999) and may not check for 
understanding (Epstein & Street, 2007; Lobb, Butow, Kenny, & Tattersall, 1999). Based 
on this tendency to overestimate ability by both patients and physicians, further research 
is needed on the exclusive use of subjective numeracy measures in research and clinical 
practice. Currently, use of objective numeracy measures may be the most accurate and 
direct way to identify low numerate patients.   
This study also provides evidence that the TDM process is more complex than the 
ability to understand treatment information. Patient preferences and beliefs also provide 
important insight into the willingness and ability that patients have to attend to 
information provided to them in a treatment consultation. Most patients preferred the use 
of numerical information in treatment consultations, but the discrepancy between 
patient’s subjective and objective numerical ability highlights the need for information to 
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be adapted to a level that they can understand. A significant number of patients 
interviewed in this study also expressed the desire for information to be tailored to each 
patient. Not only is this consistent with evidence that tailoring information leads to 
improved attention and processing, (Hawkins, Kreuter, Resnicow, Fishbein, & Dijkstra, 
2008; Kreuter & Wray, 2003; Petty & Cacioppo, 1981) but in this study it also seems to 
be consistent with patient preferences. A number of excellent reviews have condensed 
research findings on easing this process for patients and can be referenced for concrete 
suggestions for clinical practice (Lipkus, 2007; Lipkus & Peters, 2009; Nelson et al., 
2008; Peters, Hibbard, Slovic, & Dieckmann, 2007).  
Finally, the qualitative data from this study provides unique insight into the 
reasons behind patient preferences for the type of treatment information they receive. 
There were varied perceptions of the need for treatment information in this study, 
indicating that it may be helpful to assess these preferences in practice to improve patient 
engagement. A number of these preferences, such as numerical anxiety and avoidance of 
numbers, may be associated with low numeracy. Assessing patient preferences may be an 
additional way for physicians to identify patients that are uncomfortable with the use of 
numbers or their role in the TDM process. This conclusion is supported by a recent study 
on individuals from the general population in the United States and Germany (Galesic & 
Garcia-Retamero, 2011). This study found that about one-third of low numerate patients 
preferred to take a more passive role in the TDM process than they typically do, while 
high numerate patients were more satisfied with their role.  
Patients may disregard numerical treatment information because of confusion, 
lack of understanding, or they may wish to take a more passive role in the TDM process. 
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These distinctions must be made in order to ensure that patients are participating in the 
process at the level they desire and are provided information at a level consistent with 
their desired role. Additionally, patients may hold some beliefs, such as religious faith, 
that may limit their desire to engage in the TDM process. However, regardless of the 
level of participation patients wish to have in this process, it is still necessary to provide 
information to patients in a way that ensures that physicians are obtaining informed 
consent for treatment (Sheridan, Harris, & Woolf, 2004). Therefore, the results from this 
study, in conjuction with previous research findings, suggest that a thorough assessment 
that includes patient’s preferred role for decision making, objective numeracy, and 
preferences for information format may aid in obtaining informed consent and 
encouraging shared decision making (Alper, & Quill, 2004; Eggly et al., 2009; Sheridan, 
Harris, & Woolf, 2004). 
 Future Research and Conclusions 
 This study provides insight into the measurement of patient numerical ability and 
patient preferences during the TDM process. One important area for future research 
includes further study of the measurement of subjective numeracy in practice. 
Overestimation of numerical ability in this study and others highlights the need to 
determine the quickest and most accurate way to identify patients who may have more 
difficulty understanding numerical treatment information.  
In addition, this study also points out the potential benefit of continuing to assess 
patient’s desired role in the TDM process, as well as patient preferences for the type of 
treatment information they receive. Future research should continue to investigate the 
implications of incorporating patient preferences into the TDM process. It is yet unknown 
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the potential ramifications of discrepancies between patient preferences for information 
format and the type of information they receive. This study also uncovered potential 
barriers toward engagement in shared decision making that are associated with but may 
be distinct from numerical ability. These barriers may be more difficult to identify during 
the TDM process and require further elucidation. It will be helpful for future studies to 
examine how personal beliefs, such as religious beliefs, may impact the level of 
engagement a patient has in a shared decision making model.  
The results from this study provide further insight into how patients experience the TDM 
process. It is hoped that the information gathered from this study will lead to further 
refinement of communicating treatment information in a clear and understandable way. 
As shared decision making becomes the norm, it is essential to continue to balance the 
ethical duty of obtaining informed consent with patient abilities, preferences, and beliefs.  
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